How long should I stay on these medications?

Semaglutide and Tirzepatide are currently approved by the FDA for long-term use in the treatment of obesity.

Patients who stop the medication gain back on average two thirds of the weight they had lost. It is recommended that patients remain on a maintenance dose to curb cravings and maintain the new weight.

Updated on: 01/05/2024